Accuray Incorporated(ARAY) stock price and fundamentals

Medical - Devices · Madison, WI

$0.31+0.01 (+2.09%)

Delayed quote: Oct 6, 2026, 10:05 AM EDT

About Accuray Incorporated

Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region. Among their core offerings is the CyberKnife System, a sophisticated robotic platform for stereotactic radiosurgery and stereotactic body radiation therapy. This system is employed to target both primary and metastatic tumors located outside the brain, specifically addressing areas such as the spine, breast, kidney, liver, lung, pancreas, and prostate. They also provide the TomoTherapy System, which encompasses the Radixact System, designed to deliver highly precise radiation treatments (up to 50 patients daily) through integrated planning, delivery, and data management capabilities. Complementing these are the iDMS data management system and the Accuray precision treatment planning system, both offering comprehensive solutions for treatment planning and data handling. In addition to their technology, Accuray offers crucial post-sale services, including customer support, system installation, training, and various other professional services. The company primarily engages directly with its clientele, which includes hospitals and specialized treatment centers, through its dedicated sales force. In the United States, they also leverage sales agents and group purchasing organizations, while internationally, their reach extends through distributors and sales agents. Established in 1990, Accuray Incorporated maintains its corporate headquarters in Madison, Wisconsin.

Madison, WI

809 employees

www.accuray.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Stephen R. LaNeve

View full financials

Stock	Market Cap	Close Price	Price Change	TTM Total Return	5Y CAGR	10Y CAGR	Compare
1ARAY	$36.64M	$0.31	+2.09%	-82.00%	-39.94%	-25.77%	N/A
2BCTX	$36.45M	$4.19	+0.24%	-67.87%	-67.32%	-52.81%	vs ARAY
3DCGO	$36.38M	$0.37	+0.90%	-71.09%	-48.40%	N/A	vs ARAY
4ELTX	$36.04M	$1.89	-1.56%	-82.46%	N/A	N/A	vs ARAY
5ELUT	$35.82M	$0.81	-1.38%	-6.61%	-33.96%	N/A	vs ARAY
6EDSA	$38.53M	$4.00	+2.30%	+52.43%	-39.88%	-40.32%	vs ARAY

Period	Low	Avg	High	# Analysts
Quarter ending Sep 2026	$-0.07	$-0.07	$-0.07	1
Quarter ending Dec 2026	$-0.07	$-0.07	$-0.07	1
Quarter ending Mar 2027	$-0.07	$-0.07	$-0.07	1
Quarter ending Jun 2027	$-0.03	$-0.03	$-0.03	1

Period	Low	Avg	High	# Analysts
FY 2027	$-0.24	$-0.24	$-0.24	1
FY 2028	$-0.14	$-0.14	$-0.14	1

Period	Low	Avg	High	# Analysts
Quarter ending Sep 2026	$95.80M	$95.80M	$95.80M	1
Quarter ending Dec 2026	$99.99M	$99.99M	$99.99M	1
Quarter ending Mar 2027	$106.94M	$106.94M	$106.94M	1
Quarter ending Jun 2027	$109.45M	$109.45M	$109.45M	1

FY 2027	$413.00M	$413.00M	$413.00M	1
FY 2028	$422.70M	$422.70M	$422.70M	1

Accuray Incorporated(ARAY) stock price and fundamentals

Valuation

Yields

ARAY Price Chart

Business at a glance

ARAY Key Metrics

Total Return CAGR

ARAY Fundamental Charts

Revenue CAGR

Operating Cash Flow CAGR

ARAY Selected Revenue Disclosures

Product / business disclosures (FY 2026)

Geographic disclosures (FY 2026)

ARAY Earnings Preview

Similar-Size Sector Stocks

ARAY Competitors' Key Metrics

ARAY Charts

Valuation Charts

Performance Charts

Dividend Charts

CAGR Charts

Financial Statement Charts

Other Charts

ARAY Analyst Ratings

ARAY Analyst Estimates

Earnings Per Share (EPS) Estimates

Revenue Estimates